Neurocrine Biosciences (NBIX) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $157.47 +0.45%
Revenue Growth %: +30.8%
Financial Fact:
Net income (loss): -36.89M
Today's EPS Names:
RCBC, GASS, YSG, More
Revenue Growth %: +30.8%
Financial Fact:
Net income (loss): -36.89M
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q2 EPS of ($0.46), $0.03 better than the analyst estimate of ($0.49).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Mining said to delay IPO of American gold business to 2027
- J.P. Morgan cuts NIO to Neutral, slashes price target on weak demand outlook
- Bernstein SocGen: 'We view AI as a significant long-term opportunity for UnitedHealth Group (UNH)'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
